BUY Supriya Lifescience Limited — Kush Bohra

Entry₹992.2Inferred
Target₹1,055
Total upside +6.33% (call closed)
Stop loss₹990-0.22% risk
Exit₹99029 Sept 2026, 2:50 pm
Stop-loss hit-0.22%

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 29 Sept 2026
5 supporting0 opposing
Supports the BUY call (5)

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·29 Sept · today

Supriya Lifescience FY26 net profit rises 11% to ₹2,091.2 million

NewsGoogle News·27 Sept · 2d ago

(opens in new tab)

Supriya Lifescience Limited Approves Final Dividend for the Financial Year Ended March 31, 2026

NewsGoogle News·25 Sept · 3d ago

(opens in new tab)

Supriya Lifescience FY26 net profit rises 11% to ₹2,091.2 million

NewsGoogle News·20 Sept · 1w ago

(opens in new tab)

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·6 Jul · 3mo ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.